| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Litchev Boyan Vesselinov serves as a Chief Medical Officer at INDP. Across recent SEC filings that breaks down to 4 buys and 0 sells. Those positions are worth an estimated $2K at current prices.
Historically, Litchev Boyan Vesselinov's trades have earned a below-average insider score of 34/100 across 4 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -21.0%.
The biggest single holding is INDP (~$2K) as Chief Medical Officer. Net of sales, the recent Form 4 record there shows accumulation of 1,150 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | INDP Indaptus Therapeutics, Inc. | Chief Medical Officer | Buy | 1,150 | $2.19 | $2,520.08 | New | -5.0% | +22.9% |